{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:08:48Z","timestamp":1790431728220,"version":"4.1.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DST-INSPIRE"},{"name":"Mukhyamantri Research Fellowship (MRF), Higher Education Department, Government of Odisha."},{"name":"Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Government of India"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12602-024-10396-z","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:53:40Z","timestamp":1730804020000},"page":"2653-2672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance"],"prefix":"10.1007","volume":"17","author":[{"given":"Debabrata","family":"Dash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Kumar","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"4","key":"10396_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrgastro.2016.195","volume":"14","author":"A O'Connor","year":"2017","unstructured":"O\u2019Connor A, O\u2019Morain CA, Ford AC (2017) Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 14(4):230\u2013240. https:\/\/doi.org\/10.1038\/nrgastro.2016.195","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10396_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/14789450.2017.1331739","volume":"14","author":"G Bernardini","year":"2017","unstructured":"Bernardini G, Figura N, Ponzetto A, Marzocchi B, Santucci A (2017) Application of proteomics to the study of Helicobacter pylori and implications for the clinic. Expert Rev Proteomics 14(6):477\u2013490. https:\/\/doi.org\/10.1080\/14789450.2017.1331739","journal-title":"Expert Rev Proteomics"},{"issue":"2","key":"10396_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","volume":"22","author":"LM Brown","year":"2000","unstructured":"Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22(2):283\u2013297. https:\/\/doi.org\/10.1093\/oxfordjournals.epirev.a018040","journal-title":"Epidemiol Rev"},{"key":"10396_CR4","doi-asserted-by":"publisher","unstructured":"Ansari S, Yamaoka Y (2017) Survival of Helicobacter pylori in gastric acidic territory. Helicobacter 22(4). https:\/\/doi.org\/10.1111\/hel.12386","DOI":"10.1111\/hel.12386"},{"key":"10396_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1146\/annurev-med-042220-020814","volume":"73","author":"YC Lee","year":"2022","unstructured":"Lee YC, Dore MP, Graham DY (2022) Diagnosis and treatment of helicobacter pylori infection. Annu Rev Med 73:183\u2013195. https:\/\/doi.org\/10.1146\/annurev-med-042220-020814","journal-title":"Annu Rev Med"},{"issue":"4","key":"10396_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/hel.12291","volume":"21","author":"TL Ang","year":"2016","unstructured":"Ang TL, Fock KM, Ang D, Kwek AB, Teo EK, Dhamodaran S (2016) The changing profile of Helicobacter pylori antibiotic resistance in Singapore: a 15-year study. Helicobacter 21(4):261\u2013265. https:\/\/doi.org\/10.1111\/hel.12291","journal-title":"Helicobacter"},{"issue":"4","key":"10396_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA (2016) Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 43(4):514\u2013533. https:\/\/doi.org\/10.1111\/apt.13497","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10396_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1556\/030.62.2015.3.6","volume":"62","author":"TM Karpi\u0144ski","year":"2015","unstructured":"Karpi\u0144ski TM, Andrzejewska E, Eder P, Linke K, Szkaradkiewicz A (2015) Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland. Acta Microbiol Immunol Hung 62(3):287\u2013293. https:\/\/doi.org\/10.1556\/030.62.2015.3.6","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"Suppl1","key":"10396_CR9","first-page":"S47","volume":"9","author":"M Goudarzi","year":"2016","unstructured":"Goudarzi M, Heidary M, Azad M, Fazeli M, Goudarzi H (2016) Evaluation of antimicrobial susceptibility and integron carriage in Helicobacter pylori isolates from patients. Gastroenterol Hepatol Bed Bench 9(Suppl1):S47-s52","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"12","key":"10396_CR10","doi-asserted-by":"publisher","first-page":"e0166199","DOI":"10.1371\/journal.pone.0166199","volume":"11","author":"M Miftahussurur","year":"2016","unstructured":"Miftahussurur M, Syam AF, Nusi IA, Makmun D, Waskito LA, Zein LH et al (2016) Surveillance of Helicobacter pylori antibiotic susceptibility in indonesia: different resistance types among regions and with novel genetic mutations. PLoS ONE 11(12):e0166199. https:\/\/doi.org\/10.1371\/journal.pone.0166199","journal-title":"PLoS ONE"},{"key":"10396_CR11","doi-asserted-by":"publisher","unstructured":"Regnath T, Raecke O, Enninger A, Ignatius R (2017) Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany. Helicobacter 22(1). https:\/\/doi.org\/10.1111\/hel.12327","DOI":"10.1111\/hel.12327"},{"issue":"5","key":"10396_CR12","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E (2018) Prevalence of antibiotic resistance in helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology 155(5):1372\u201382 e17. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.007","journal-title":"Gastroenterology"},{"issue":"9","key":"10396_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","volume":"18","author":"E Tshibangu-Kabamba","year":"2021","unstructured":"Tshibangu-Kabamba E, Yamaoka Y (2021) Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol 18(9):613\u2013629. https:\/\/doi.org\/10.1038\/s41575-021-00449-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10396_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S2468-1253(23)00354-0","volume":"9","author":"KA Fauzia","year":"2024","unstructured":"Fauzia KA, Tuan VP (2024) Rising resistance: antibiotic choices for Helicobacter pylori infection. Lancet Gastroenterol Hepatol 9(1):7\u20138. https:\/\/doi.org\/10.1016\/S2468-1253(23)00354-0","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10396_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/1040841x.2017.1418285","volume":"44","author":"Y Gong","year":"2018","unstructured":"Gong Y, Yuan Y (2018) Resistance mechanisms of Helicobacter pylori and its dual target precise therapy. Crit Rev Microbiol 44(3):371\u2013392. https:\/\/doi.org\/10.1080\/1040841x.2017.1418285","journal-title":"Crit Rev Microbiol"},{"key":"10396_CR16","doi-asserted-by":"publisher","unstructured":"Tuan VP, Narith D, Tshibangu-Kabamba E, Dung HDQ, Viet PT, Sokomoth S et al (2019) A next-generation sequencing-based approach to identify genetic determinants of antibiotic resistance in Cambodian Helicobacter pylori clinical isolates. J Clin Med 8(6). https:\/\/doi.org\/10.3390\/jcm8060858","DOI":"10.3390\/jcm8060858"},{"key":"10396_CR17","doi-asserted-by":"publisher","unstructured":"Lauener FN, Imkamp F, Lehours P, Buissonni\u00e8re A, Benejat L, Zbinden R et al (2019) Genetic determinants and prediction of antibiotic resistance phenotypes in Helicobacter pylori. J Clin Med 8(1). https:\/\/doi.org\/10.3390\/jcm8010053","DOI":"10.3390\/jcm8010053"},{"issue":"4","key":"10396_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1586\/eri.10.14","volume":"8","author":"KE Fujimura","year":"2010","unstructured":"Fujimura KE, Slusher NA, Cabana MD, Lynch SV (2010) Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 8(4):435\u2013454. https:\/\/doi.org\/10.1586\/eri.10.14","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"9","key":"10396_CR19","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1136\/gutjnl-2019-319696","volume":"69","author":"Y Guo","year":"2020","unstructured":"Guo Y, Zhang Y, Gerhard M, Gao JJ, Mejias-Luque R, Zhang L et al (2020) Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer. Gut 69(9):1598\u20131607. https:\/\/doi.org\/10.1136\/gutjnl-2019-319696","journal-title":"Gut"},{"issue":"23","key":"10396_CR20","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1007\/s00253-020-10945-w","volume":"104","author":"P Roszczenko-Jasi\u0144ska","year":"2020","unstructured":"Roszczenko-Jasi\u0144ska P, Wojty\u015b MI, Jagusztyn-Krynicka EK (2020) Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets. Appl Microbiol Biotechnol 104(23):9891\u20139905. https:\/\/doi.org\/10.1007\/s00253-020-10945-w","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"10396_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2169\/internalmedicine.2521-18","volume":"59","author":"S Kiyotoki","year":"2020","unstructured":"Kiyotoki S, Nishikawa J, Sakaida I (2020) Efficacy of vonoprazan for Helicobacter pylori eradication. Intern Med 59(2):153\u2013161. https:\/\/doi.org\/10.2169\/internalmedicine.2521-18","journal-title":"Intern Med"},{"issue":"3","key":"10396_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000504939","volume":"102","author":"S Shinozaki","year":"2021","unstructured":"Shinozaki S, Kobayashi Y, Osawa H, Sakamoto H, Hayashi Y, Lefor AK, Yamamoto H (2021) Effectiveness and safety of vonoprazan versus proton pump inhibitors for second-line Helicobacter pylori eradication therapy: systematic review and meta-analysis. Digestion 102(3):319\u2013325. https:\/\/doi.org\/10.1159\/000504939","journal-title":"Digestion"},{"issue":"1","key":"10396_CR23","doi-asserted-by":"publisher","first-page":"e12555","DOI":"10.1111\/hel.12555","volume":"24","author":"A Neshani","year":"2019","unstructured":"Neshani A, Zare H, Akbari Eidgahi MR, Hooshyar Chichaklu A, Movaqar A, Ghazvini K (2019) Review of antimicrobial peptides with anti-Helicobacter pylori activity. Helicobacter 24(1):e12555. https:\/\/doi.org\/10.1111\/hel.12555","journal-title":"Helicobacter"},{"key":"10396_CR24","doi-asserted-by":"publisher","first-page":"120745","DOI":"10.1016\/j.biomaterials.2021.120745","volume":"271","author":"BN Im","year":"2021","unstructured":"Im BN, Shin H, Lim B, Lee J, Kim KS, Park JM, Na K (2021) Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy. Biomaterials 271:120745. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120745","journal-title":"Biomaterials"},{"issue":"4","key":"10396_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/1541-4337.12355","volume":"17","author":"Q Liu","year":"2018","unstructured":"Liu Q, Meng X, Li Y, Zhao CN, Tang GY, Li S et al (2018) Natural products for the prevention and management of helicobacter pylori infection. Compr Rev Food Sci Food Saf 17(4):937\u2013952. https:\/\/doi.org\/10.1111\/1541-4337.12355","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"1","key":"10396_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00253-017-8535-7","volume":"102","author":"K Goderska","year":"2018","unstructured":"Goderska K, Agudo Pena S, Alarcon T (2018) Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol 102(1):1\u20137. https:\/\/doi.org\/10.1007\/s00253-017-8535-7","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"10396_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Atherton J, Axon AT, Bazzoli F et al (2012) Management of Helicobacter pylori infection\u2013the Maastricht IV\/ Florence Consensus Report. Gut 61(5):646\u2013664. https:\/\/doi.org\/10.1136\/gutjnl-2012-302084","journal-title":"Gut"},{"issue":"3","key":"10396_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1523-5378.2008.00595.x","volume":"13","author":"L Zhang","year":"2008","unstructured":"Zhang L, Su P, Henriksson A, O\u2019Rourke J, Mitchell H (2008) Investigation of the immunomodulatory effects of Lactobacillus casei and Bifidobacterium lactis on Helicobacter pylori infection. Helicobacter 13(3):183\u2013190. https:\/\/doi.org\/10.1111\/j.1523-5378.2008.00595.x","journal-title":"Helicobacter"},{"issue":"10","key":"10396_CR29","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.3168\/jds.2010-3274","volume":"93","author":"Y Shirasawa","year":"2010","unstructured":"Shirasawa Y, Shibahara-Sone H, Iino T, Ishikawa F (2010) Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells. J Dairy Sci 93(10):4526\u20134534. https:\/\/doi.org\/10.3168\/jds.2010-3274","journal-title":"J Dairy Sci"},{"issue":"1","key":"10396_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MCG.0b013e318266f6cf","volume":"47","author":"ZH Wang","year":"2013","unstructured":"Wang ZH, Gao QY, Fang JY (2013) Meta-analysis of the efficacy and safety of Lactobacillus-containing and bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol 47(1):25\u201332. https:\/\/doi.org\/10.1097\/MCG.0b013e318266f6cf","journal-title":"J Clin Gastroenterol"},{"issue":"15","key":"10396_CR31","doi-asserted-by":"publisher","first-page":"e15180","DOI":"10.1097\/MD.0000000000015180","volume":"98","author":"X Shi","year":"2019","unstructured":"Shi X, Zhang J, Mo L, Shi J, Qin M, Huang X (2019) Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis. Medicine (Baltimore) 98(15):e15180. https:\/\/doi.org\/10.1097\/MD.0000000000015180","journal-title":"Medicine (Baltimore)"},{"key":"10396_CR32","doi-asserted-by":"publisher","first-page":"1120789","DOI":"10.3389\/fcimb.2023.1120789","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang X, Cao XY, Zhu HL, Miao L (2023) Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis. Front Cell Infect Microbiol 13:1120789. https:\/\/doi.org\/10.3389\/fcimb.2023.1120789","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10396_CR33","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1099\/ijsem.0.004107","volume":"70","author":"J Zheng","year":"2020","unstructured":"Zheng J, Wittouck S, Salvetti E, Franz C, Harris HMB, Mattarelli P et al (2020) A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol 70(4):2782\u20132858. https:\/\/doi.org\/10.1099\/ijsem.0.004107","journal-title":"Int J Syst Evol Microbiol"},{"key":"10396_CR34","doi-asserted-by":"publisher","unstructured":"De Angelis M, Gobbetti M (2011) Lactobacillus SPP.: general characteristics. Reference Module in Food Science. Elsevier, Amsterdam, pp 78-90. https:\/\/doi.org\/10.1016\/B978-0-08-100596-5.00851-9","DOI":"10.1016\/B978-0-08-100596-5.00851-9"},{"issue":"6","key":"10396_CR35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3168\/jds.S0022-0302(97)76027-2","volume":"80","author":"P Marteau","year":"1997","unstructured":"Marteau P, Minekus M, Havenaar R, Huis in\u2019t Veld JH (1997) Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci 80(6):1031\u20137. https:\/\/doi.org\/10.3168\/jds.S0022-0302(97)76027-2","journal-title":"J Dairy Sci"},{"issue":"10","key":"10396_CR36","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1128\/jcm.27.10.2328-2330.1989","volume":"27","author":"SJ Bhatia","year":"1989","unstructured":"Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP (1989) Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 27(10):2328\u20132330. https:\/\/doi.org\/10.1128\/jcm.27.10.2328-2330.1989","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10396_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2672.1995.tb03164.x","volume":"79","author":"PD Midolo","year":"1995","unstructured":"Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML (1995) In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 79(4):475\u2013479. https:\/\/doi.org\/10.1111\/j.1365-2672.1995.tb03164.x","journal-title":"J Appl Bacteriol"},{"issue":"11","key":"10396_CR38","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1128\/AEM.64.11.4573-4580.1998","volume":"64","author":"MH Coconnier","year":"1998","unstructured":"Coconnier MH, Lievin V, Hemery E, Servin AL (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64(11):4573\u20134580. https:\/\/doi.org\/10.1128\/AEM.64.11.4573-4580.1998","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10396_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000007660","volume":"60","author":"P Michetti","year":"1999","unstructured":"Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M et al (1999) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60(3):203\u2013209. https:\/\/doi.org\/10.1159\/000007660","journal-title":"Digestion"},{"issue":"12","key":"10396_CR40","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1046\/j.1365-2036.2000.00885.x","volume":"14","author":"F Canducci","year":"2000","unstructured":"Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P et al (2000) A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14(12):1625\u20131629. https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00885.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10396_CR41","first-page":"S79","volume":"85","author":"RK Vilaichone","year":"2002","unstructured":"Vilaichone RK, Mahachai V, Tumwasorn S, Nunthapisud P, Kullavanijaya P (2002) Inhibitory effect of Lactobacillus acidophilus on Helicobacter pylori in peptic ulcer patients: in vitro study. J Med Assoc Thailand = Chotmaihet Thangphaet 85(Suppl 1):S79-84","journal-title":"J Med Assoc Thailand = Chotmaihet Thangphaet"},{"issue":"1\u20132","key":"10396_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1023\/a:1021649427988","volume":"243","author":"A Chatterjee","year":"2003","unstructured":"Chatterjee A, Yasmin T, Bagchi D, Stohs SJ (2003) The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin compared to clarithromycin, on Helicobacter pylori. Mol Cell Biochem 243(1\u20132):29\u201335. https:\/\/doi.org\/10.1023\/a:1021649427988","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10396_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11274-012-1203-2","volume":"29","author":"M Zhang","year":"2013","unstructured":"Zhang M, Zhang H, Li Y, Qi W, Wang X, Wang J (2013) Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro. World J Microbiol Biotechnol 29(3):499\u2013504. https:\/\/doi.org\/10.1007\/s11274-012-1203-2","journal-title":"World J Microbiol Biotechnol"},{"key":"10396_CR44","doi-asserted-by":"publisher","first-page":"e1794","DOI":"10.31661\/gmj.v9i0.1794","volume":"9","author":"S Taghizadeh","year":"2020","unstructured":"Taghizadeh S, Falsafi T, Kermanshahi RK, Ramezani R (2020) Antagonistic and immunomodulant effects of two probiotic strains of Lactobacillus on clinical strains of Helicobacter pylori. Galen Med J 9:e1794. https:\/\/doi.org\/10.31661\/gmj.v9i0.1794","journal-title":"Galen Med J"},{"key":"10396_CR45","doi-asserted-by":"publisher","first-page":"1196084","DOI":"10.3389\/fcimb.2023.1196084","volume":"13","author":"S Shen","year":"2023","unstructured":"Shen S, Ren F, Qin H, Bukhari I, Yang J, Gao D et al (2023) Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model. Front Cell Infect Microbiol 13:1196084. https:\/\/doi.org\/10.3389\/fcimb.2023.1196084","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10396_CR46","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1128\/AEM.70.1.518-526.2004","volume":"70","author":"D Sgouras","year":"2004","unstructured":"Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S et al (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 70(1):518\u2013526. https:\/\/doi.org\/10.1128\/AEM.70.1.518-526.2004","journal-title":"Appl Environ Microbiol"},{"key":"10396_CR47","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fmicb.2014.00766","volume":"5","author":"S Delgado","year":"2014","unstructured":"Delgado S, Leite AM, Ruas-Madiedo P, Mayo B (2014) Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis. Front Microbiol 5:766. https:\/\/doi.org\/10.3389\/fmicb.2014.00766","journal-title":"Front Microbiol"},{"issue":"8","key":"10396_CR48","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.3390\/nu5083062","volume":"5","author":"H Mehling","year":"2013","unstructured":"Mehling H, Busjahn A (2013) Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass\u2122) as a new approach to Helicobacter pylori control in humans. Nutrients 5(8):3062\u20133073. https:\/\/doi.org\/10.3390\/nu5083062","journal-title":"Nutrients"},{"key":"10396_CR49","doi-asserted-by":"publisher","unstructured":"Dargenio C, Dargenio VN, Bizzoco F, Indrio F, Francavilla R, Cristofori F (2021) Limosilactobacillus reuteri strains as adjuvants in the management of Helicobacter pylori Infection. Medicina (Kaunas, Lithuania) 57(7). https:\/\/doi.org\/10.3390\/medicina57070733","DOI":"10.3390\/medicina57070733"},{"issue":"5","key":"10396_CR50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1472-765X.2009.02571.x","volume":"48","author":"L Boyanova","year":"2009","unstructured":"Boyanova L, Stephanova-Kondratenko M, Mitov I (2009) Anti-Helicobacter pylori activity of Lactobacillus delbrueckii subsp. bulgaricus strains: preliminary report. Lett Appl Microbiol 48(5):579\u201384. https:\/\/doi.org\/10.1111\/j.1472-765X.2009.02571.x","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"10396_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jmii.2014.04.014","volume":"49","author":"PX Zheng","year":"2016","unstructured":"Zheng PX, Fang HY, Yang HB, Tien NY, Wang MC, Wu JJ (2016) Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. J Microbiol Immunol Infect = Wei Mian Yu Gan Ran Za Zhi 49(2):168\u201374. https:\/\/doi.org\/10.1016\/j.jmii.2014.04.014","journal-title":"J Microbiol Immunol Infect = Wei Mian Yu Gan Ran Za Zhi"},{"issue":"10","key":"10396_CR52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/08927014.2016.1249367","volume":"32","author":"MJ Salas-Jara","year":"2016","unstructured":"Salas-Jara MJ, Sanhueza EA, Retamal-D\u00edaz A, Gonz\u00e1lez C, Urrutia H, Garc\u00eda A (2016) Probiotic Lactobacillus fermentum UCO-979C biofilm formation on AGS and Caco-2 cells and Helicobacter pylori inhibition. Biofouling 32(10):1245\u20131257. https:\/\/doi.org\/10.1080\/08927014.2016.1249367","journal-title":"Biofouling"},{"issue":"21","key":"10396_CR53","doi-asserted-by":"publisher","first-page":"11024","DOI":"10.1039\/d1fo01480c","volume":"12","author":"S Kang","year":"2021","unstructured":"Kang S, Guo Y, Rao J, Jin H, You HJ, Ji GE (2021) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus plantarum pH3A, monolaurin, and grapefruit seed extract. Food Funct 12(21):11024\u201311032. https:\/\/doi.org\/10.1039\/d1fo01480c","journal-title":"Food Funct"},{"issue":"2","key":"10396_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.34172\/bi.2020.09","volume":"10","author":"H Maleki-Kakelar","year":"2020","unstructured":"Maleki-Kakelar H, Dehghani J, Barzegari A, Barar J, Shirmohamadi M, Sadeghi J, Omidi Y (2020) Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori. BioImpacts: BI 10(2):65\u201372. https:\/\/doi.org\/10.34172\/bi.2020.09","journal-title":"BioImpacts: BI"},{"issue":"1","key":"10396_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/gut.41.1.49","volume":"41","author":"AM Kabir","year":"1997","unstructured":"Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y (1997) Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41(1):49\u201355. https:\/\/doi.org\/10.1136\/gut.41.1.49","journal-title":"Gut"},{"key":"10396_CR56","doi-asserted-by":"publisher","unstructured":"Jin F, Yang H (2021) Effects of Lactobacillus salivarius LN12 in combination with amoxicillin and clarithromycin on Helicobacter pylori biofilm in vitro. Microorganisms 9(8). https:\/\/doi.org\/10.3390\/microorganisms9081611","DOI":"10.3390\/microorganisms9081611"},{"key":"10396_CR57","doi-asserted-by":"publisher","unstructured":"Hu J, Tian X, Wei T, Wu H, Lu J, Lyu M, Wang S (2021) Anti-helicobacter pylori activity of a lactobacillus sp. PW-7 exopolysaccharide. Foods (Basel, Switzerland) 10(10). https:\/\/doi.org\/10.3390\/foods10102453","DOI":"10.3390\/foods10102453"},{"issue":"10","key":"10396_CR58","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.22038\/ijbms.2019.33321.7953","volume":"22","author":"P Rezaee","year":"2019","unstructured":"Rezaee P, Kermanshahi RK, Falsafi T (2019) Antibacterial activity of lactobacilli probiotics on clinical strains of Helicobacter pylori. Iran J Basic Med Sci 22(10):1118\u201324. https:\/\/doi.org\/10.22038\/ijbms.2019.33321.7953","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"10396_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00431-018-3282-z","volume":"178","author":"HR Fang","year":"2019","unstructured":"Fang HR, Zhang GQ, Cheng JY, Li ZY (2019) Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials. Eur J Pediatr 178(1):7\u201316. https:\/\/doi.org\/10.1007\/s00431-018-3282-z","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10396_CR60","doi-asserted-by":"publisher","first-page":"e0223309","DOI":"10.1371\/journal.pone.0223309","volume":"14","author":"M Yu","year":"2019","unstructured":"Yu M, Zhang R, Ni P, Chen S, Duan G (2019) Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: a meta-analysis of randomized controlled trials. PloS One 14(10):e0223309. https:\/\/doi.org\/10.1371\/journal.pone.0223309","journal-title":"PloS One"},{"issue":"37","key":"10396_CR61","doi-asserted-by":"publisher","first-page":"10644","DOI":"10.3748\/wjg.v21.i37.10644","volume":"21","author":"M Homan","year":"2015","unstructured":"Homan M, Orel R (2015) Are probiotics useful in Helicobacter pylori eradication? World J Gastroenterol 21(37):10644\u201310653. https:\/\/doi.org\/10.3748\/wjg.v21.i37.10644","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10396_CR62","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-2672.2007.03279.x","volume":"103","author":"B Batdorj","year":"2007","unstructured":"Batdorj B, Trinetta V, Dalgalarrondo M, Pr\u00e9vost H, Dousset X, Ivanova I et al (2007) Isolation, taxonomic identification and hydrogen peroxide production by Lactobacillus delbrueckii subsp. lactis T31, isolated from Mongolian yoghurt: inhibitory activity on food-borne pathogens. J Appl Microbiol 103(3):584\u201393. https:\/\/doi.org\/10.1111\/j.1365-2672.2007.03279.x","journal-title":"J Appl Microbiol"},{"issue":"1","key":"10396_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4315\/0362-028x-66.1.3","volume":"66","author":"TS Kim","year":"2003","unstructured":"Kim TS, Hur JW, Yu MA, Cheigh CI, Kim KN, Hwang JK, Pyun YR (2003) Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 66(1):3\u201312. https:\/\/doi.org\/10.4315\/0362-028x-66.1.3","journal-title":"J Food Prot"},{"issue":"3b","key":"10396_CR64","first-page":"543","volume":"66","author":"L Avonts","year":"2001","unstructured":"Avonts L, De Vuyst L (2001) Antimicrobial potential of probiotic lactic acid bacteria. Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet 66(3b):543\u2013550","journal-title":"Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet"},{"issue":"2","key":"10396_CR65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12602-017-9342-2","volume":"10","author":"VH Urrutia-Baca","year":"2018","unstructured":"Urrutia-Baca VH, Escamilla-Garc\u00eda E, de la Garza-Ramos MA, Tamez-Guerra P, Gomez-Flores R, Urbina-R\u00edos CS (2018) In vitro antimicrobial activity and downregulation of virulence gene expression on Helicobacter pylori by reuterin. Probiotics Antimicrob Proteins 10(2):168\u2013175. https:\/\/doi.org\/10.1007\/s12602-017-9342-2","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"2","key":"10396_CR66","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1365-2672.2008.04052.x","volume":"106","author":"ED Simova","year":"2009","unstructured":"Simova ED, Beshkova DB, Dimitrov ZhP (2009) Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products. J Appl Microbiol 106(2):692\u2013701. https:\/\/doi.org\/10.1111\/j.1365-2672.2008.04052.x","journal-title":"J Appl Microbiol"},{"issue":"6","key":"10396_CR67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/lam.12807","volume":"65","author":"L Boyanova","year":"2017","unstructured":"Boyanova L, Gergova G, Markovska R, Yordanov D, Mitov I (2017) Bacteriocin-like inhibitory activities of seven Lactobacillus delbrueckii subsp. bulgaricus strains against antibiotic susceptible and resistant Helicobacter pylori strains. Lett Appl Microbiol 65(6):469\u201374. https:\/\/doi.org\/10.1111\/lam.12807","journal-title":"Lett Appl Microbiol"},{"issue":"1","key":"10396_CR68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12602-009-9029-4","volume":"2","author":"L De Vuyst","year":"2010","unstructured":"De Vuyst L, Vincent P, Makras E, Leroy F, Pot B (2010) Peptide extracts from cultures of certain Lactobacilli inhibit Helicobacter pylori. Probiotics Antimicrob Proteins 2(1):26\u201336. https:\/\/doi.org\/10.1007\/s12602-009-9029-4","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10396_CR69","doi-asserted-by":"publisher","unstructured":"Zuo F, Somiah T, Gebremariam HG, Jonsson AB (2022) Lactobacilli downregulate transcription factors in Helicobacter pylori that affect motility, acid tolerance and antimicrobial peptide survival. Int J Mol Sci 23(24). https:\/\/doi.org\/10.3390\/ijms232415451","DOI":"10.3390\/ijms232415451"},{"issue":"12","key":"10396_CR70","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1128\/cdli.12.12.1378-1386.2005","volume":"12","author":"DN Sgouras","year":"2005","unstructured":"Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A (2005) Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL\/6 mice. Clin Diagn Lab Immunol 12(12):1378\u20131386. https:\/\/doi.org\/10.1128\/cdli.12.12.1378-1386.2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"32","key":"10396_CR71","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.3748\/wjg.14.5090","volume":"14","author":"C Zhou","year":"2008","unstructured":"Zhou C, Ma FZ, Deng XJ, Yuan H, Ma HS (2008) Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4. World J Gastroenterol 14(32):5090\u20135095. https:\/\/doi.org\/10.3748\/wjg.14.5090","journal-title":"World J Gastroenterol"},{"issue":"Pt 8","key":"10396_CR72","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1099\/jmm.0.009407-0","volume":"58","author":"KA Ryan","year":"2009","unstructured":"Ryan KA, O\u2019Hara AM, van Pijkeren JP, Douillard FP, O\u2019Toole PW (2009) Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori. J Med Microbiol 58(Pt 8):996\u20131005. https:\/\/doi.org\/10.1099\/jmm.0.009407-0","journal-title":"J Med Microbiol"},{"issue":"20","key":"10396_CR73","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3748\/wjg.v18.i20.2472","volume":"18","author":"C Sunanliganon","year":"2012","unstructured":"Sunanliganon C, Thong-Ngam D, Tumwasorn S, Klaikeaw N (2012) Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammation. World J Gastroenterol 18(20):2472\u20132480. https:\/\/doi.org\/10.3748\/wjg.v18.i20.2472","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10396_CR74","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/hel.12105","volume":"19","author":"T Thiraworawong","year":"2014","unstructured":"Thiraworawong T, Spinler JK, Werawatganon D, Klaikeaw N, Venable SF, Versalovic J, Tumwasorn S (2014) Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection. Helicobacter 19(2):144\u2013155. https:\/\/doi.org\/10.1111\/hel.12105","journal-title":"Helicobacter"},{"issue":"4","key":"10396_CR75","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13577-017-0172-z","volume":"30","author":"S Takeda","year":"2017","unstructured":"Takeda S, Igoshi K, Tsend-Ayush C, Oyunsuren T, Sakata R, Koga Y et al (2017) Lactobacillus paracasei strain 06TCa19 suppresses inflammatory chemokine induced by Helicobacter pylori in human gastric epithelial cells. Hum Cell 30(4):258\u2013266. https:\/\/doi.org\/10.1007\/s13577-017-0172-z","journal-title":"Hum Cell"},{"key":"10396_CR76","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3389\/fimmu.2019.02326","volume":"10","author":"HG Gebremariam","year":"2019","unstructured":"Gebremariam HG, Qazi KR, Somiah T, Pathak SK, Sj\u00f6linder H, Sverremark Ekstr\u00f6m E, Jonsson AB (2019) Lactobacillus gasseri suppresses the production of proinflammatory cytokines in Helicobacter pylori-Infected macrophages by inhibiting the expression of ADAM17. Front Immunol 10:2326. https:\/\/doi.org\/10.3389\/fimmu.2019.02326","journal-title":"Front Immunol"},{"key":"10396_CR77","doi-asserted-by":"publisher","unstructured":"Garcia-Castillo V, Marcial G, Albarrac\u00edn L, Tomokiyo M, Clua P, Takahashi H et al (2020) The Exopolysaccharide of Lactobacillus fermentum UCO-979C is partially involved in its immunomodulatory effect and its ability to improve the resistance against Helicobacter pylori infection. Microorganisms 8(4). https:\/\/doi.org\/10.3390\/microorganisms8040479","DOI":"10.3390\/microorganisms8040479"},{"issue":"3","key":"10396_CR78","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12602-020-09721-z","volume":"13","author":"M Yarmohammadi","year":"2021","unstructured":"Yarmohammadi M, Yadegar A, Ebrahimi MT, Zali MR (2021) Effects of a potential probiotic strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-induced inflammatory response and gene expression in coinfected gastric epithelial cells. Probiotics Antimicrob Proteins 13(3):751\u2013764. https:\/\/doi.org\/10.1007\/s12602-020-09721-z","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"23","key":"10396_CR79","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1021\/acs.jafc.1c01070","volume":"69","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Xue B, Gu R, Li P, Gu Q (2021) Lactobacillus plantarum ZJ316 attenuates Helicobacter pylori-induced gastritis in C57BL\/6 mice. J Agric Food Chem 69(23):6510\u20136523. https:\/\/doi.org\/10.1021\/acs.jafc.1c01070","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10396_CR80","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1111\/hel.12806","volume":"26","author":"AD Do","year":"2021","unstructured":"Do AD, Chang CC, Su CH, Hsu YM (2021) Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions. Helicobacter 26(3):e12806. https:\/\/doi.org\/10.1111\/hel.12806","journal-title":"Helicobacter"},{"issue":"4","key":"10396_CR81","doi-asserted-by":"publisher","first-page":"e12898","DOI":"10.1111\/hel.12898","volume":"27","author":"C He","year":"2022","unstructured":"He C, Peng C, Xu X, Li N, Ouyang Y, Zhu Y, Lu N (2022) Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota. Helicobacter 27(4):e12898. https:\/\/doi.org\/10.1111\/hel.12898","journal-title":"Helicobacter"},{"issue":"8","key":"10396_CR82","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1007\/s11033-023-08596-x","volume":"50","author":"F Fakharian","year":"2023","unstructured":"Fakharian F, Sadeghi A, Pouresmaeili F, Soleimani N, Yadegar A (2023) Immunomodulatory effects of live and pasteurized Lactobacillus crispatus strain RIGLD-1 on Helicobacter pylori-triggered inflammation in gastric epithelial cells in vitro. Mol Biol Rep 50(8):6795\u20136805. https:\/\/doi.org\/10.1007\/s11033-023-08596-x","journal-title":"Mol Biol Rep"},{"issue":"7","key":"10396_CR83","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1111\/1750-3841.16616","volume":"88","author":"R Wei","year":"2023","unstructured":"Wei R, Zhu C, Chen S, Wang J, Zeng Z, Lan L et al (2023) Preventive therapeutic effect of Lactobacillus-fermented black wolfberry juice on sodium dextran sulfate-induced ulcerative colitis in mice. J Food Sci 88(7):3102\u20133118. https:\/\/doi.org\/10.1111\/1750-3841.16616","journal-title":"J Food Sci"},{"issue":"2","key":"10396_CR84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1574-695X.2002.tb00541.x","volume":"32","author":"T Mukai","year":"2002","unstructured":"Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H (2002) Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 32(2):105\u2013110. https:\/\/doi.org\/10.1111\/j.1574-695X.2002.tb00541.x","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"12","key":"10396_CR85","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.3168\/jds.2010-3449","volume":"93","author":"X Chen","year":"2010","unstructured":"Chen X, Tian F, Liu X, Zhao J, Zhang HP, Zhang H, Chen W (2010) In vitro screening of lactobacilli with antagonistic activity against Helicobacter pylori from traditionally fermented foods. J Dairy Sci 93(12):5627\u20135634. https:\/\/doi.org\/10.3168\/jds.2010-3449","journal-title":"J Dairy Sci"},{"issue":"6","key":"10396_CR86","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1523-5378.2012.00992.x","volume":"17","author":"PS Hsieh","year":"2012","unstructured":"Hsieh PS, Tsai YC, Chen YC, Teh SF, Ou CM, King VA (2012) Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter 17(6):466\u201377. https:\/\/doi.org\/10.1111\/j.1523-5378.2012.00992.x","journal-title":"Helicobacter"},{"issue":"3","key":"10396_CR87","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11845-013-0909-y","volume":"182","author":"H El-Adawi","year":"2013","unstructured":"El-Adawi H, El-Sheekh M, Khalil M, El-Deeb N, Hussein M (2013) Lactic acid bacterial extracts as anti-Helicobacter pylori: a molecular approach. Ir J Med Sci 182(3):439\u2013452. https:\/\/doi.org\/10.1007\/s11845-013-0909-y","journal-title":"Ir J Med Sci"},{"issue":"2","key":"10396_CR88","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12602-014-9181-3","volume":"7","author":"C Holz","year":"2015","unstructured":"Holz C, Busjahn A, Mehling H, Arya S, Boettner M, Habibi H, Lang C (2015) Significant reduction in Helicobacter pylori load in humans with non-viable Lactobacillus reuteri DSM17648: a pilot study. Probiotics Antimicrob Proteins 7(2):91\u2013100. https:\/\/doi.org\/10.1007\/s12602-014-9181-3","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"5","key":"10396_CR89","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1128\/IAI.00163-16","volume":"84","author":"N de Klerk","year":"2016","unstructured":"de Klerk N, Maudsdotter L, Gebreegziabher H, Saroj SD, Eriksson B, Eriksson OS et al (2016) Lactobacilli reduce Helicobacter pylori attachment to host gastric epithelial cells by inhibiting adhesion gene expression. Infect Immun 84(5):1526\u20131535. https:\/\/doi.org\/10.1128\/IAI.00163-16","journal-title":"Infect Immun"},{"key":"10396_CR90","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3389\/fmicb.2019.02770","volume":"10","author":"F Zuo","year":"2019","unstructured":"Zuo F, Appaswamy A, Gebremariam HG, Jonsson AB (2019) Role of Sortase A in Lactobacillus gasseri Kx110A1 adhesion to gastric epithelial cells and competitive exclusion of Helicobacter pylori. Front Microbiol 10:2770. https:\/\/doi.org\/10.3389\/fmicb.2019.02770","journal-title":"Front Microbiol"},{"key":"10396_CR91","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fcimb.2020.00248","volume":"10","author":"M Herath","year":"2020","unstructured":"Herath M, Hosie S, Bornstein JC, Franks AE, Hill-Yardin EL (2020) The role of the gastrointestinal mucus system in intestinal homeostasis: implications for neurological disorders. Front Cell Infect Microbiol 10:248. https:\/\/doi.org\/10.3389\/fcimb.2020.00248","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10396_CR92","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/0046-8177(92)90132-m","volume":"23","author":"PK Hui","year":"1992","unstructured":"Hui PK, Chan WY, Cheung PS, Chan JK, Ng CS (1992) Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol 23(5):548\u2013556. https:\/\/doi.org\/10.1016\/0046-8177(92)90132-m","journal-title":"Hum Pathol"},{"issue":"6","key":"10396_CR93","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/s0016-5085(00)70360-x","volume":"118","author":"JC Byrd","year":"2000","unstructured":"Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS (2000) Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology 118(6):1072\u20131079. https:\/\/doi.org\/10.1016\/s0016-5085(00)70360-x","journal-title":"Gastroenterology"},{"issue":"6","key":"10396_CR94","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1136\/gut.52.6.827","volume":"52","author":"DR Mack","year":"2003","unstructured":"Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA (2003) Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52(6):827\u2013833. https:\/\/doi.org\/10.1136\/gut.52.6.827","journal-title":"Gut"},{"issue":"8","key":"10396_CR95","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1046\/j.1365-2036.2003.01675.x","volume":"18","author":"D Pantoflickova","year":"2003","unstructured":"Pantoflickova D, Corthesy-Theulaz I, Dorta G, Stolte M, Isler P, Rochat F et al (2003) Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Aliment Pharmacol Ther 18(8):805\u2013813. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01675.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10396_CR96","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1046\/j.1440-1746.2003.03102.x","volume":"18","author":"A Ushiyama","year":"2003","unstructured":"Ushiyama A, Tanaka K, Aiba Y, Shiba T, Takagi A, Mine T, Koga Y (2003) Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J Gastroenterol Hepatol 18(8):986\u2013991. https:\/\/doi.org\/10.1046\/j.1440-1746.2003.03102.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"7\u20138","key":"10396_CR97","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1023\/b:ddas.0000037794.02040.c2","volume":"49","author":"KC Johnson-Henry","year":"2004","unstructured":"Johnson-Henry KC, Mitchell DJ, Avitzur Y, Galindo-Mata E, Jones NL, Sherman PM (2004) Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 49(7\u20138):1095\u2013102. https:\/\/doi.org\/10.1023\/b:ddas.0000037794.02040.c2","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10396_CR98","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1128\/IAI.73.2.912-920.2005","volume":"73","author":"JA Pena","year":"2005","unstructured":"Pena JA, Rogers AB, Ge Z, Ng V, Li SY, Fox JG, Versalovic J (2005) Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun 73(2):912\u201320. https:\/\/doi.org\/10.1128\/IAI.73.2.912-920.2005","journal-title":"Infect Immun"},{"issue":"1","key":"10396_CR99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.0083-8703.2006.00373.x","volume":"11","author":"T Brzozowski","year":"2006","unstructured":"Brzozowski T, Konturek PC, Mierzwa M, Drozdowicz D, Bielanski W, Kwiecien S et al (2006) Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils. Helicobacter 11(1):10\u201320. https:\/\/doi.org\/10.1111\/j.0083-8703.2006.00373.x","journal-title":"Helicobacter"},{"issue":"4","key":"10396_CR100","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1271\/bbb.110921","volume":"76","author":"H Isobe","year":"2012","unstructured":"Isobe H, Nishiyama A, Takano T, Higuchi W, Nakagawa S, Taneike I et al (2012) Reduction of overall Helicobacter pylori colonization levels in the stomach of Mongolian gerbil by Lactobacillus johnsonii La1 (LC1) and its in vitro activities against H. pylori motility and adherence. Biosci Biotechnol Biochem 76(4):850\u20132. https:\/\/doi.org\/10.1271\/bbb.110921","journal-title":"Biosci Biotechnol Biochem"},{"issue":"4","key":"10396_CR101","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/hel.12203","volume":"20","author":"H Matsui","year":"2015","unstructured":"Matsui H, Takahashi T, Overby A, Murayama SY, Yoshida H, Yamamoto Y et al (2015) Mouse models for assessing the protective efficacy of Lactobacillus gasseri SBT2055 against Helicobacter suis infection associated with the development of gastric mucosa-associated lymphoid tissue lymphoma. Helicobacter 20(4):291\u2013298. https:\/\/doi.org\/10.1111\/hel.12203","journal-title":"Helicobacter"},{"issue":"3","key":"10396_CR102","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/mbo3.252","volume":"4","author":"Y Aiba","year":"2015","unstructured":"Aiba Y, Nakano Y, Koga Y, Takahashi K, Komatsu Y (2015) A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice. MicrobiologyOpen 4(3):465\u201374. https:\/\/doi.org\/10.1002\/mbo3.252","journal-title":"MicrobiologyOpen"},{"issue":"2","key":"10396_CR103","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3168\/jds.2015-10510","volume":"99","author":"M Pan","year":"2016","unstructured":"Pan M, Wan C, Xie Q, Huang R, Tao X, Shah NP, Wei H (2016) Changes in gastric microbiota induced by Helicobacter pylori infection and preventive effects of Lactobacillus plantarum ZDY 2013 against such infection. J Dairy Sci 99(2):970\u2013981. https:\/\/doi.org\/10.3168\/jds.2015-10510","journal-title":"J Dairy Sci"},{"key":"10396_CR104","doi-asserted-by":"publisher","unstructured":"Aiba Y, Ishikawa H, Tokunaga M, Komatsu Y (2017) Anti-Helicobacter pylori activity of non-living, heat-killed form of lactobacilli including Lactobacillus johnsonii No.1088. FEMS Microbiol Lett 364(11). https:\/\/doi.org\/10.1093\/femsle\/fnx102","DOI":"10.1093\/femsle\/fnx102"},{"issue":"4","key":"10396_CR105","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3920\/bm2017.0160","volume":"9","author":"JS Merino","year":"2018","unstructured":"Merino JS, Garc\u00eda A, Pastene E, Salas A, Saez K, Gonz\u00e1lez CL (2018) Lactobacillus fermentum UCO-979C strongly inhibited Helicobacter pylori SS1 in Meriones unguiculatus. Benefic Microbes 9(4):625\u2013627. https:\/\/doi.org\/10.3920\/bm2017.0160","journal-title":"Benefic Microbes"},{"issue":"12","key":"10396_CR106","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1111\/1750-3841.14372","volume":"83","author":"ME Chen","year":"2018","unstructured":"Chen ME, Su CH, Yang JS, Lu CC, Hou YC, Wu JB, Hsu YM (2018) Baicalin, Baicalein, and Lactobacillus Rhamnosus JB3 alleviated Helicobacter pylori infections in vitro and in vivo. J Food Sci 83(12):3118\u20133125. https:\/\/doi.org\/10.1111\/1750-3841.14372","journal-title":"J Food Sci"},{"key":"10396_CR107","doi-asserted-by":"crossref","unstructured":"Amin Afsahi HM, Azizalah Ebrahimi, Zahra Aeini and Davoud Esmaeili (2018) Evaluation of the effect of Lactobacillus planetarium probiotics produced from broad bean seed in prevention of Helicobacter pylori in stomach tissue of C57BL\/6 mice. J Cancer Sci Therapy 10(4):85-89","DOI":"10.4172\/1948-5956.1000524"},{"issue":"4","key":"10396_CR108","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5625\/lar.2018.34.4.216","volume":"34","author":"SS Hong","year":"2018","unstructured":"Hong SS, Lee HA, Kim JY, Jeong JW, Shim JJ, Lee JL et al (2018) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacilllus paracasei HP7. Lab Anim Res 34(4):216\u2013222. https:\/\/doi.org\/10.5625\/lar.2018.34.4.216","journal-title":"Lab Anim Res"},{"key":"10396_CR109","doi-asserted-by":"publisher","unstructured":"Lin CC, Huang WC, Su CH, Lin WD, Wu WT, Yu B, Hsu YM (2020) Effects of multi-strain probiotics on immune responses and metabolic balance in Helicobacter pylori-infected mice. Nutrients 12(8). https:\/\/doi.org\/10.3390\/nu12082476","DOI":"10.3390\/nu12082476"},{"key":"10396_CR110","doi-asserted-by":"publisher","first-page":"972569","DOI":"10.3389\/fnut.2022.972569","volume":"9","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Qureshi N, Xue B, Xie Z, Li P, Gu Q (2022) Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model. Front Nutr 9:972569. https:\/\/doi.org\/10.3389\/fnut.2022.972569","journal-title":"Front Nutr"},{"issue":"21","key":"10396_CR111","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1039\/d2fo02034c","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Li Z, Zhao L, Wang J, Wang F, Zhang Q et al (2022) Two novel lactic acid bacteria, Limosilactobacillus fermentum MN-LF23 and Lactobacillus gasseri MN-LG80, inhibited Helicobacter pylori infection in C57BL\/6 mice. Food Funct 13(21):11061\u201311069. https:\/\/doi.org\/10.1039\/d2fo02034c","journal-title":"Food Funct"},{"key":"10396_CR112","doi-asserted-by":"publisher","first-page":"1320819","DOI":"10.3389\/fcimb.2023.1320819","volume":"13","author":"YY Yu","year":"2023","unstructured":"Yu YY, Wu LY, Sun X, Gu Q, Zhou QQ (2023) Effect of Lactobacillus plantarum ZFM4 in Helicobacter pylori-infected C57BL\/6 mice: prevention is better than cure. Front Cell Infect Microbiol 13:1320819. https:\/\/doi.org\/10.3389\/fcimb.2023.1320819","journal-title":"Front Cell Infect Microbiol"},{"issue":"18","key":"10396_CR113","doi-asserted-by":"publisher","first-page":"e2300241","DOI":"10.1002\/mnfr.202300241","volume":"67","author":"S Wu","year":"2023","unstructured":"Wu S, Xu Y, Chen Z, Chen Y, Wei F, Xia C et al (2023) Lactiplantibacillus plantarum ZJ316 reduces Helicobacter pylori adhesion and inflammation by inhibiting the expression of adhesin and urease genes. Mol Nutr Food Res 67(18):e2300241. https:\/\/doi.org\/10.1002\/mnfr.202300241","journal-title":"Mol Nutr Food Res"},{"key":"10396_CR114","doi-asserted-by":"publisher","first-page":"114903","DOI":"10.1016\/j.bbr.2024.114903","volume":"463","author":"NS Seddighi","year":"2024","unstructured":"Seddighi NS, Beheshti F, Masoudi M, Tabrizi AMA, Asl AAH, Ahmadi-Soleimani SM, Azizi O (2024) Oral administration of bacterial probiotics improves Helicobacter pylori-induced memory impairment in rats: Insights from behavioral and biochemical investigations. Behav Brain Res 463:114903. https:\/\/doi.org\/10.1016\/j.bbr.2024.114903","journal-title":"Behav Brain Res"},{"issue":"1","key":"10396_CR115","doi-asserted-by":"publisher","first-page":"10069","DOI":"10.1038\/s41598-024-59399-4","volume":"14","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zhou Y, Han Z, He K, Zhang Y, Wu D, Chen H (2024) The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses. Sci Rep 14(1):10069. https:\/\/doi.org\/10.1038\/s41598-024-59399-4","journal-title":"Sci Rep"},{"issue":"2","key":"10396_CR116","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2036.2001.00923.x","volume":"15","author":"A Armuzzi","year":"2001","unstructured":"Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V et al (2001) The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 15(2):163\u2013169. https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00923.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10396_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000051865","volume":"63","author":"A Armuzzi","year":"2001","unstructured":"Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M et al (2001) Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 63(1):1\u20137. https:\/\/doi.org\/10.1159\/000051865","journal-title":"Digestion"},{"issue":"11","key":"10396_CR118","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1111\/j.1572-0241.2002.07063.x","volume":"97","author":"F Cremonini","year":"2002","unstructured":"Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L et al (2002) Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97(11):2744\u20132749. https:\/\/doi.org\/10.1111\/j.1572-0241.2002.07063.x","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10396_CR119","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/mpg.0b013e318182e716","volume":"48","author":"H Szajewska","year":"2009","unstructured":"Szajewska H, Albrecht P, Topczewska-Cabanek A (2009) Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J Pediatr Gastroenterol Nutr 48(4):431\u2013436. https:\/\/doi.org\/10.1097\/mpg.0b013e318182e716","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"10396_CR120","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/s0899-9007(03)00109-6","volume":"19","author":"S Cruchet","year":"2003","unstructured":"Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M (2003) Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 19(9):716\u2013721. https:\/\/doi.org\/10.1016\/s0899-9007(03)00109-6","journal-title":"Nutrition"},{"issue":"8","key":"10396_CR121","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/01.mcg.0000173855.77191.44","volume":"39","author":"J Sykora","year":"2005","unstructured":"Sykora J, Valeckova K, Amlerova J, Siala K, Dedek P, Watkins S et al (2005) Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 39(8):692\u20138. https:\/\/doi.org\/10.1097\/01.mcg.0000173855.77191.44","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 3","key":"10396_CR122","first-page":"123","volume":"57","author":"W Ziemniak","year":"2006","unstructured":"Ziemniak W (2006) Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. J Physiol Pharmacol 57(Suppl 3):123\u2013141","journal-title":"J Physiol Pharmacol"},{"issue":"10","key":"10396_CR123","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1365-2036.2006.03145.x","volume":"24","author":"E Lionetti","year":"2006","unstructured":"Lionetti E, Miniello VL, Castellaneta SP, Magist\u00e1 AM, de Canio A, Maurogiovanni G et al (2006) Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 24(10):1461\u20131468. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03145.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10396_CR124","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1523-5378.2008.00593.x","volume":"13","author":"R Francavilla","year":"2008","unstructured":"Francavilla R, Lionetti E, Castellaneta SP, Magist\u00e0 AM, Maurogiovanni G, Bucci N et al (2008) Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 13(2):127\u2013134. https:\/\/doi.org\/10.1111\/j.1523-5378.2008.00593.x","journal-title":"Helicobacter"},{"issue":"4","key":"10396_CR125","first-page":"251","volume":"12","author":"G Scaccianoce","year":"2008","unstructured":"Scaccianoce G, Zullo A, Hassan C, Gentili F, Cristofari F, Cardinale V et al (2008) Triple therapies plus different probiotics for Helicobacter pylori eradication. Eur Rev Med Pharmacol Sci 12(4):251\u2013256","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"43","key":"10396_CR126","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.3748\/wjg.v18.i43.6250","volume":"18","author":"C Efrati","year":"2012","unstructured":"Efrati C, Nicolini G, Cannaviello C, O\u2019Sed NP, Valabrega S (2012) Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation. World J Gastroenterol 18(43):6250\u20136254. https:\/\/doi.org\/10.3748\/wjg.v18.i43.6250","journal-title":"World J Gastroenterol"},{"key":"10396_CR127","doi-asserted-by":"publisher","first-page":"740381","DOI":"10.1155\/2012\/740381","volume":"2012","author":"V Ojetti","year":"2012","unstructured":"Ojetti V, Bruno G, Ainora ME, Gigante G, Rizzo G, Roccarina D, Gasbarrini A (2012) Impact of Lactobacillus reuteri supplementation on anti-Helicobacter pylori levofloxacin-based second-line therapy. Gastroenterol Res Pract 2012:740381. https:\/\/doi.org\/10.1155\/2012\/740381","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10396_CR128","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/mcg.0000000000000007","volume":"48","author":"R Francavilla","year":"2014","unstructured":"Francavilla R, Polimeno L, Demichina A, Maurogiovanni G, Principi B, Scaccianoce G et al (2014) Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. J Clin Gastroenterol 48(5):407\u2013413. https:\/\/doi.org\/10.1097\/mcg.0000000000000007","journal-title":"J Clin Gastroenterol"},{"issue":"15","key":"10396_CR129","doi-asserted-by":"publisher","first-page":"e3411","DOI":"10.1097\/md.0000000000003411","volume":"95","author":"MP Dore","year":"2016","unstructured":"Dore MP, Soro S, Rocchi C, Loria MF, Bibb\u00f2 S, Pes GM (2016) Inclusion of Lactobacillus reuteri in the treatment of helicobacter pylori in Sardinian patients: a case report series. Medicine (Baltimore) 95(15):e3411. https:\/\/doi.org\/10.1097\/md.0000000000003411","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10396_CR130","doi-asserted-by":"publisher","first-page":"e12659","DOI":"10.1111\/hel.12659","volume":"24","author":"MP Dore","year":"2019","unstructured":"Dore MP, Bibb\u00f2 S, Loria M, Salis R, Manca A, Pes GM, Graham DY (2019) Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera\u00ae or Lactobacillus reuteri for treatment na\u00efve or for retreatment of Helicobacter pylori. Two randomized pilot studies. Helicobacter 24(6):e12659. https:\/\/doi.org\/10.1111\/hel.12659","journal-title":"Helicobacter"},{"issue":"9","key":"10396_CR131","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.31557\/APJCP.2019.20.9.2859","volume":"20","author":"P Poonyam","year":"2019","unstructured":"Poonyam P, Chotivitayatarakorn P, Vilaichone RK (2019) High effective of 14-day high-dose PPI- bismuth-containing quadruple therapy with probiotics supplement for Helicobacter Pylori eradication: a double blinded-randomized placebo-controlled study. Asian Pac J Cancer Prev 20(9):2859\u201364. https:\/\/doi.org\/10.31557\/APJCP.2019.20.9.2859","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10396_CR132","doi-asserted-by":"publisher","first-page":"e13017","DOI":"10.1111\/hel.13017","volume":"28","author":"NI Ismail","year":"2023","unstructured":"Ismail NI, Nawawi KNM, Hsin DCC, Hao KW, Mahmood N, Chearn GLC et al (2023) Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: a randomized, double-blind, placebo-controlled trial. Helicobacter 28(6):e13017. https:\/\/doi.org\/10.1111\/hel.13017","journal-title":"Helicobacter"},{"issue":"1","key":"10396_CR133","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajg.2022.10.004","volume":"24","author":"M Mohtasham","year":"2023","unstructured":"Mohtasham M, Joukar F, Maroufizadeh S, Mojtahedi K, Asgharnezhad M, Mansour-Ghanaei F (2023) Lactobacillus ruteri compared with placebo as an adjuvant in quadruple therapy for Helicobacter pylori eradication: a randomized, double-blind, controlled trial. Arab J Gastroenterol 24(1):40\u201344. https:\/\/doi.org\/10.1016\/j.ajg.2022.10.004","journal-title":"Arab J Gastroenterol"},{"issue":"6","key":"10396_CR134","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11739-013-1013-z","volume":"9","author":"MP Dore","year":"2014","unstructured":"Dore MP, Cuccu M, Pes GM, Manca A, Graham DY (2014) Lactobacillus reuteri in the treatment of Helicobacter pylori infection. Intern Emerg Med 9(6):649\u2013654. https:\/\/doi.org\/10.1007\/s11739-013-1013-z","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10396_CR135","doi-asserted-by":"publisher","first-page":"352","DOI":"10.15386\/mpr-1375","volume":"92","author":"IAP Muresan","year":"2019","unstructured":"Muresan IAP, Pop LL, Dumitrascu DL (2019) Lactobacillus reuteri versus triple therapy for the eradication of Helicobacter pylori in functional dyspepsia. Med Pharm Rep 92(4):352\u20135. https:\/\/doi.org\/10.15386\/mpr-1375","journal-title":"Med Pharm Rep"},{"key":"10396_CR136","doi-asserted-by":"publisher","first-page":"3409820","DOI":"10.1155\/2019\/3409820","volume":"2019","author":"MP Dore","year":"2019","unstructured":"Dore MP, Bibbo S, Pes GM, Francavilla R, Graham DY (2019) Role of Probiotics in Helicobacter pylori eradication: lessons from a study of Lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 (Gastrus(R)) and a proton-pump inhibitor. Can J Infect Dis Med Microbiol 2019:3409820. https:\/\/doi.org\/10.1155\/2019\/3409820","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10396_CR137","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40795-018-0257-4","volume":"4","author":"M Buckley","year":"2018","unstructured":"Buckley M, Lacey S, Doolan A, Goodbody E, Seamans K (2018) The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study. BMC Nutr 4:48. https:\/\/doi.org\/10.1186\/s40795-018-0257-4","journal-title":"BMC Nutr"},{"key":"10396_CR138","doi-asserted-by":"publisher","first-page":"6432750","DOI":"10.1155\/2022\/6432750","volume":"2022","author":"S Wang","year":"2022","unstructured":"Wang S, Zhang M, Yu L, Tian F, Lu W, Wang G et al (2022) Evaluation of the potential protective effects of Lactobacillus strains against Helicobacter pylori infection: a randomized, double-blinded, placebo-controlled trial. Can J Infect Dis Med Microbiol 2022:6432750. https:\/\/doi.org\/10.1155\/2022\/6432750","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10396_CR139","doi-asserted-by":"publisher","first-page":"1265995","DOI":"10.3389\/fimmu.2023.1265995","volume":"14","author":"Q Hong","year":"2023","unstructured":"Hong Q, Wang J, Zhang H, Liu X, Liu Z (2023) Study of the effect of Lactobacillus crispatus FSCDJY67L3 on Helicobacter Pylori eradication: a double-blind randomized controlled clinical trial. Front Immunol 14:1265995. https:\/\/doi.org\/10.3389\/fimmu.2023.1265995","journal-title":"Front Immunol"},{"issue":"1","key":"10396_CR140","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00042737-200101000-00005","volume":"13","author":"CP Felley","year":"2001","unstructured":"Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P et al (2001) Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 13(1):25\u201329. https:\/\/doi.org\/10.1097\/00042737-200101000-00005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"10396_CR141","first-page":"CR662","volume":"10","author":"A Tursi","year":"2004","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Modeo ME (2004) Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 10(12):CR662\u2013CR666","journal-title":"Med Sci Monit"},{"issue":"2","key":"10396_CR142","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1083-4389.2004.00214.x","volume":"9","author":"M Linsalata","year":"2004","unstructured":"Linsalata M, Russo F, Berloco P, Caruso ML, Matteo GD, Cifone MG et al (2004) The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 9(2):165\u2013172. https:\/\/doi.org\/10.1111\/j.1083-4389.2004.00214.x","journal-title":"Helicobacter"},{"issue":"5","key":"10396_CR143","first-page":"333","volume":"75","author":"JE Sahag\u00fan-Flores","year":"2007","unstructured":"Sahag\u00fan-Flores JE, L\u00f3pez-Pe\u00f1a LS, de la Cruz-Ram\u00edrezJaimes J, Garc\u00eda-Bravo MS, Peregrina-G\u00f3mez R, de Alba-Garc\u00eda JE (2007) Eradication of Helicobacter pylori: triple treatment scheme plus Lactobacillus vs. triple treatment alone. Cir Cirujanos 75(5):333\u2013336","journal-title":"Cir Cirujanos"},{"issue":"4","key":"10396_CR144","doi-asserted-by":"publisher","first-page":"387","DOI":"10.11150\/kansenshogakuzasshi1970.81.387","volume":"81","author":"K Imase","year":"2007","unstructured":"Imase K, Tanaka A, Tokunaga K, Sugano H, Ishida H, Takahashi S (2007) Lactobacillus reuteri tablets suppress Helicobacter pylori infection--a double-blind randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi 81(4):387\u201393. https:\/\/doi.org\/10.11150\/kansenshogakuzasshi1970.81.387","journal-title":"Kansenshogaku Zasshi"},{"issue":"3","key":"10396_CR145","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1523-5378.2009.00675.x","volume":"14","author":"S Boonyaritichaikij","year":"2009","unstructured":"Boonyaritichaikij S, Kuwabara K, Nagano J, Kobayashi K, Koga Y (2009) Long-term administration of probiotics to asymptomatic pre-school children for either the eradication or the prevention of Helicobacter pylori infection. Helicobacter 14(3):202\u2013207. https:\/\/doi.org\/10.1111\/j.1523-5378.2009.00675.x","journal-title":"Helicobacter"},{"issue":"4","key":"10396_CR146","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10096-010-1119-4","volume":"30","author":"JA Medeiros","year":"2011","unstructured":"Medeiros JA, Goncalves TM, Boyanova L, Pereira MI, de Carvalho JN, Pereira AM, Cabrita AM (2011) Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone. Eur J Clin Microbiol Infect Dis 30(4):555\u2013559. https:\/\/doi.org\/10.1007\/s10096-010-1119-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10396_CR147","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1440-1746.2011.06985.x","volume":"27","author":"R Deguchi","year":"2012","unstructured":"Deguchi R, Nakaminami H, Rimbara E, Noguchi N, Sasatsu M, Suzuki T et al (2012) Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. J Gastroenterol Hepatol 27(5):888\u2013892. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06985.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10396_CR148","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1756283x13503514","volume":"7","author":"MH Emara","year":"2014","unstructured":"Emara MH, Mohamed SY, Abdel-Aziz HR (2014) Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial. Ther Adv Gastroenterol 7(1):4\u201313. https:\/\/doi.org\/10.1177\/1756283x13503514","journal-title":"Ther Adv Gastroenterol"},{"issue":"3","key":"10396_CR149","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11655-016-2531-0","volume":"23","author":"CY Lee","year":"2017","unstructured":"Lee CY, Shih HC, Yu MC, Lee MY, Chang YL, Lai YY et al (2017) Evaluation of the potential inhibitory activity of a combination of L. acidophilus, L. rhamnosus and L. sporogenes on Helicobacter pylori: a randomized double-blind placebo-controlled clinical. Chin J Integr Med 23(3):176\u201382. https:\/\/doi.org\/10.1007\/s11655-016-2531-0","journal-title":"Chin J Integr Med"},{"issue":"6","key":"10396_CR150","doi-asserted-by":"publisher","first-page":"e12857","DOI":"10.1111\/hel.12857","volume":"26","author":"MJ Chen","year":"2021","unstructured":"Chen MJ, Chen CC, Huang YC, Tseng CC, Hsu JT, Lin YF et al (2021) The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial. Helicobacter 26(6):e12857. https:\/\/doi.org\/10.1111\/hel.12857","journal-title":"Helicobacter"},{"issue":"6","key":"10396_CR151","doi-asserted-by":"publisher","first-page":"e12856","DOI":"10.1111\/hel.12856","volume":"26","author":"C Yang","year":"2021","unstructured":"Yang C, Liang L, Lv P, Liu L, Wang S, Wang Z, Chen Y (2021) Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: a randomized double-blind placebo-controlled trial. Helicobacter 26(6):e12856. https:\/\/doi.org\/10.1111\/hel.12856","journal-title":"Helicobacter"},{"key":"10396_CR152","doi-asserted-by":"publisher","first-page":"932331","DOI":"10.3389\/fmicb.2022.932331","volume":"13","author":"P Marinelli","year":"2022","unstructured":"Marinelli P, Scalese G, Covelli A, Ruffa A, Bedetti G, Bruno G, Severi C (2022) Lactobacillus rhamnosus GG supplementation on eradication rate and dyspepsia in Helicobacter pylori infection treated with three-in-one bismuth quadruple therapy. Front Microbiol 13:932331. https:\/\/doi.org\/10.3389\/fmicb.2022.932331","journal-title":"Front Microbiol"},{"issue":"2","key":"10396_CR153","doi-asserted-by":"publisher","first-page":"89","DOI":"10.17235\/reed.2021.7931\/2021","volume":"114","author":"C Moreno M\u00e1rquez","year":"2022","unstructured":"Moreno M\u00e1rquez C, Fern\u00e1ndez\u00c1lvarez P, Vald\u00e9s Delgado T, Castro Laria L, Arg\u00fcelles Arias F, Caunedo\u00c1lvarez \u00c1, G\u00f3mez Rodr\u00edguez BJ (2022) Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori. Rev Esp Enferm Dig Organo: Oficial Soc Esp Patol Dig 114(2):89\u201395. https:\/\/doi.org\/10.17235\/reed.2021.7931\/2021","journal-title":"Rev Esp Enferm Dig Organo: Oficial Soc Esp Patol Dig"},{"key":"10396_CR154","doi-asserted-by":"publisher","unstructured":"Dore MP, Sau R, Niolu C, Abbondio M, Tanca A, Bibbo S et al (2022) Metagenomic changes of gut microbiota following treatment of Helicobacter pylori infection with a simplified low-dose quadruple therapy with bismuth or Lactobacillus reuteri. Nutrients 14(14). https:\/\/doi.org\/10.3390\/nu14142789","DOI":"10.3390\/nu14142789"},{"issue":"3","key":"10396_CR155","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/infdis\/174.3.631","volume":"174","author":"M Jorgensen","year":"1996","unstructured":"Jorgensen M, Daskalopoulos G, Warburton V, Mitchell HM, Hazell SL (1996) Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens. J Infect Dis 174(3):631\u2013635. https:\/\/doi.org\/10.1093\/infdis\/174.3.631","journal-title":"J Infect Dis"},{"issue":"1","key":"10396_CR156","doi-asserted-by":"publisher","first-page":"2152306","DOI":"10.1080\/19490976.2022.2152306","volume":"14","author":"DJ Wilkinson","year":"2022","unstructured":"Wilkinson DJ, Dickins B, Robinson K, Winter JA (2022) Genomic diversity of Helicobacter pylori populations from different regions of the human stomach. Gut Microbes 14(1):2152306. https:\/\/doi.org\/10.1080\/19490976.2022.2152306","journal-title":"Gut Microbes"},{"key":"10396_CR157","doi-asserted-by":"publisher","unstructured":"Borner RA, Kandasamy V, Axelsen AM, Nielsen AT, Bosma EF (2019) Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech. FEMS Microbiol Lett 366(1). https:\/\/doi.org\/10.1093\/femsle\/fny291","DOI":"10.1093\/femsle\/fny291"},{"key":"10396_CR158","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.copbio.2020.12.015","volume":"70","author":"F Zuo","year":"2021","unstructured":"Zuo F, Marcotte H (2021) Advancing mechanistic understanding and bioengineering of probiotic lactobacilli and bifidobacteria by genome editing. Curr Opin Biotechnol 70:75\u201382. https:\/\/doi.org\/10.1016\/j.copbio.2020.12.015","journal-title":"Curr Opin Biotechnol"},{"issue":"6","key":"10396_CR159","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/gut.2005.076604","volume":"55","author":"P Marteau","year":"2006","unstructured":"Marteau P, Lemann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y et al (2006) Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn\u2019s disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55(6):842\u2013847. https:\/\/doi.org\/10.1136\/gut.2005.076604","journal-title":"Gut"},{"key":"10396_CR160","doi-asserted-by":"publisher","unstructured":"Dore MP, Bibbo S, Fresi G, Bassotti G, Pes GM (2019) Side effects associated with probiotic use in adult patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Nutrients 11(12). https:\/\/doi.org\/10.3390\/nu11122913","DOI":"10.3390\/nu11122913"},{"issue":"6","key":"10396_CR161","doi-asserted-by":"publisher","first-page":"e01358","DOI":"10.1128\/mBio.01358-15","volume":"6","author":"C Gao","year":"2015","unstructured":"Gao C, Major A, Rendon D, Lugo M, Jackson V, Shi Z et al (2015) Histamine H2 receptor-mediated suppression of intestinal inflammation by probiotic Lactobacillus reuteri. mBio 6(6):e01358-15. https:\/\/doi.org\/10.1128\/mBio.01358-15","journal-title":"mBio"},{"key":"10396_CR162","doi-asserted-by":"publisher","unstructured":"Borka Balas R, Melit LE, Marginean CO (2022) Worldwide prevalence and risk factors of Helicobacter pylori infection in children. Children (Basel) 9(9). https:\/\/doi.org\/10.3390\/children9091359","DOI":"10.3390\/children9091359"},{"issue":"2","key":"10396_CR163","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D et al (2017) Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153(2):420\u2013429. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.022","journal-title":"Gastroenterology"},{"issue":"1","key":"10396_CR164","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12879-023-08504-5","volume":"23","author":"M Shirani","year":"2023","unstructured":"Shirani M, Pakzad R, Haddadi MH, Akrami S, Asadi A, Kazemian H et al (2023) The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. BMC Infect Dis 23(1):543. https:\/\/doi.org\/10.1186\/s12879-023-08504-5","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10396_CR165","doi-asserted-by":"publisher","first-page":"e13103","DOI":"10.1111\/hel.13103","volume":"29","author":"Y Yu","year":"2024","unstructured":"Yu Y, Xue J, Lin F, Liu D, Zhang W, Ru S, Jiang F (2024) Global primary antibiotic resistance rate of Helicobacter pylori in recent 10 years: a systematic review and meta-analysis. Helicobacter 29(3):e13103. https:\/\/doi.org\/10.1111\/hel.13103","journal-title":"Helicobacter"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-024-10396-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:05:58Z","timestamp":1760619958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-024-10396-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":165,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10396"],"URL":"https:\/\/doi.org\/10.1007\/s12602-024-10396-z","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"29 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}